The company has introduced Scribe v3 Medical alongside new voice AI models, agent automation features and enterprise partnerships with McKinsey and Nvidia.
AI voice technology company ElevenLabs has introduced Scribe v3 Medical, a speech-to-text model designed for healthcare applications, alongside new AI models and enterprise automation capabilities. The expansion includes tools for customising AI systems, managing conversational workflows and deploying industry-specific voice agents.
Announced on November 13, 2026, Scribe v3 Medical is optimised for healthcare transcription, with ElevenLabs also outlining plans to develop specialised models for other sectors, including financial services.
The company has introduced three additional voice models: Scribe v3 for speech-to-text transcription, Eleven v4 for expressive text-to-speech generation and Eleven Realtime for speech-to-speech interactions.
Selected enterprise customers will also be able to collaborate with ElevenLabs' research team to fine-tune audio models and large language models according to their operational requirements.
The company said businesses can use information from live deployments and reinforcement learning techniques to improve AI performance against measures such as customer satisfaction and system reliability.
Alongside these developments, ElevenLabs has introduced Interaction Engine, a system designed to coordinate voice models and large language models during conversations.
The technology selects models based on individual tasks, with the aim of balancing response quality, reliability and computing costs.
ElevenLabs has also expanded ElevenAgents, its platform for deploying AI-powered voice and chat agents across customer support, sales, recruitment and business operations.
The updated platform includes Memory, which allows agents to retain information from previous customer interactions, and Routines, which automates multi-step activities before, during and after conversations.
Another feature, Architect, enables businesses to create and modify AI agents through voice or text instructions. Proposed changes undergo simulation testing and are presented for approval before implementation.
To support enterprise adoption, ElevenLabs has introduced a partner programme involving more than 550 firms across 44 countries.
The company has also announced an alliance with McKinsey to support organisations developing and scaling AI agents.
Its expanded partnership with Nvidia includes the availability of Nemotron 3.5 Super VL within ElevenAgents and plans to add 15 megawatts of Vera Rubin computing capacity.
The two companies will also collaborate on developing an on-premises voice agent for Poland's national e-Health platform.
Additionally, ElevenLabs is launching a marketplace featuring industry-specific AI agents developed by more than 20 partners.
The developments follow ElevenLabs' recent agreement with the Karnataka government to promote responsible voice AI adoption across citizen services, accessibility and social initiatives.
Under the agreement, the company committed to restoring one million voices for individuals who have permanently lost their ability to speak due to medical conditions.
The latest announcements expand ElevenLabs' offerings across healthcare transcription, enterprise AI deployment and conversational automation, with a focus on industry-specific applications and business workflows.
Disclaimer: This article may include information derived from interviews, press releases, public statements, research, company communications and other publicly available or third-party sources. Such material may be summarised, paraphrased or contextualised for journalistic and editorial purposes. All rights in third-party content remain with their respective owners.